Dimethylformamide dimethyl acetal → HCID 13281184、化合物
反応式
[N:1]1([CH2:6][CH2:7][CH:8]2[CH2:13][CH2:12][NH:11][CH2:10][CH2:9]2)[CH:5]=[CH:4][N:3]=[CH:2]1.[CH3:14][O:15][CH:16]([O:20][CH3:21])N(C)C>>[CH3:14][O:15][CH:16]([O:20][CH3:21])[N:11]1[CH2:12][CH2:13][CH:8]([CH2:7][CH2:6][N:1]2[CH:5]=[CH:4][N:3]=[CH:2]2)[CH2:9][CH2:10]1参加物
実験手順
The free base 4[2-(imidazol-1-yl)ethyl]piperidine (5.1 g, 28.7 mM) and dimethylformamide dimethyl acetal (23 ml) was heated at 100° C. for 6 hours. Removal of the excess of dimethylformamide dimethyl acetal gave 4-[2-(imidazol-1-yl)ethyl]-1-piperidine carboxaldehyde dimethylacetal (6.32 g, 87%) which was dissolved in CH2Cl2 (27 ml) and added to the mixture of 6-aminopenicillanic acid (5.6 g., 258 mM) and diisopropylethylamine (3.41 ml) in CH2Cl2 (100 ml) at 0° C. The reaction was stirred at 0° C. for 1 hr. and room temperature for 3 hrs. The solvent was then removed and water (100 ml) was added. After being washed with ethylacetate, the aqueous solution, acidified to pH 3, was purified on Sephadex LH 20 columns to give [2S-(2alpha,5alpha,6beta)]-6-[[[4 -[2-(1H-imidazol-1-yl)ethyl]-1-piperidinyl]methylene]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid hydrate hydrochloride (1.8 g, 16% yield).
後処理
- customRemoval of the excess of dimethylformamide dimethyl acetal
出典と根拠
- ORDレコード
- ord-f4b5d6851b18453a873c9ccb76354062
- 出典データセット
- uspto-grants-1985_08
- 特許番号
- US04537969
反応ノート
読み込み中…